(Q58573884)

English

Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany

article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

multiple drug resistance

1 reference

based on heuristic

inferred from title

antimicrobial resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

M Kresken

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H Seifert

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

E Leitner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

B Körber-Irrgang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

C von Eiff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

P-A Löschmann

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

24 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1095-1103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Infectious Diseases: Considerations for the 21st Century

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Trends in infectious disease mortality in the United States during the 20th century

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Changing patterns of infectious disease

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

The global problem of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

New antimicrobial molecules and new antibiotic strategies

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Currently available antimicrobial agents and their potential for use as monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in Germany

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007).

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1197-Y

21 January 2018

Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21347680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/21347680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21347680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-011-1197-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21347680%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58573884&oldid=2213865733"